Literature DB >> 16015218

Update: syringe exchange programs--United States, 2002.

.   

Abstract

Syringe exchange programs (SEPs) provide sterile syringes in exchange for used syringes to reduce transmission of human immunodeficiency virus (HIV) and other bloodborne infections associated with reuse of contaminated syringes by injection-drug users (IDUs). This report summarizes a survey of SEP activities in the United States for January-December 2002 and compares the results with those of previous surveys. The findings indicate that in 2002, for the first time in 8 years, the number of SEPs, the number of localities with SEPs, and public funding for SEPs decreased nationwide; however, the number of syringes exchanged and total budgets across all programs continued to increase. SEPs can help prevent bloodborne pathogen transmission by increasing access to sterile syringes among IDUs and enabling safe disposal of used syringes. Often, programs also provide other public health services, such as HIV testing, risk-reduction education, and referrals for substance-abuse treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16015218

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  16 in total

1.  Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.

Authors:  Nickolas Zaller; Alexandra Jeronimo; Jeffrey Bratberg; Patricia Case; Josiah D Rich
Journal:  J Urban Health       Date:  2010-12       Impact factor: 3.671

2.  Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas.

Authors:  Barbara Tempalski; Peter L Flom; Samuel R Friedman; Don C Des Jarlais; Judith J Friedman; Courtney McKnight; Risa Friedman
Journal:  Am J Public Health       Date:  2007-01-31       Impact factor: 9.308

3.  Approval of syringe exchange programs in California: results from a local approach to HIV prevention.

Authors:  Ricky N Bluthenthal; Keith G Heinzerling; Rachel Anderson; Neil M Flynn; Alex H Kral
Journal:  Am J Public Health       Date:  2007-05-30       Impact factor: 9.308

4.  HIV testing practices and attitudes on prevention efforts in six diverse Chicago communities.

Authors:  Kristi L Allgood; Abigail Silva; Ami Shah; Steven Whitman
Journal:  J Community Health       Date:  2009-12

5.  The Significance of Harm Reduction as a Social and Health Care Intervention for Injecting Drug Users: An Exploratory Study of a Needle Exchange Program in Fresno, California.

Authors:  Kris Clarke; Debra Harris; John A Zweifler; Marc Lasher; Roger B Mortimer; Susan Hughes
Journal:  Soc Work Public Health       Date:  2016-05-11

6.  The Ryan White HIV/AIDS Program in the Age of Health Care Reform.

Authors:  Sean R Cahill; Kenneth H Mayer; Stephen L Boswell
Journal:  Am J Public Health       Date:  2015-04-16       Impact factor: 9.308

Review 7.  Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.

Authors:  Scott S Santibanez; Richard S Garfein; Andrea Swartzendruber; David W Purcell; Lynn A Paxton; Alan E Greenberg
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

8.  Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia.

Authors:  April M Young; Richard A Crosby; Carrie B Oser; Carl G Leukefeld; Dustin B Stephens; Jennifer R Havens
Journal:  J Med Virol       Date:  2012-09       Impact factor: 2.327

9.  Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.

Authors:  Alan Neaigus; Mingfang Zhao; V Anna Gyarmathy; Linda Cisek; Samuel R Friedman; Robert C Baxter
Journal:  J Urban Health       Date:  2008-03-14       Impact factor: 3.671

10.  Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users.

Authors:  Elise D Riley; Alex H Kral; Thomas J Stopka; Richard S Garfein; Paul Reuckhaus; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.